All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F16%3A00059757" target="_blank" >RIV/00023001:_____/16:00059757 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1111/jce.12858" target="_blank" >http://dx.doi.org/10.1111/jce.12858</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/jce.12858" target="_blank" >10.1111/jce.12858</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study

  • Original language description

    NICM VT Ablation AimTo determine whether ventricular tachycardia (VT) recurrences in arrhythmogenic RV cardiomyopathy (ARVC) and nonischemic cardiomyopathy (NICM) are related to incomplete ablation or disease progression. MethodsARVC and NICM patients with two substrate maps of the same diseased ventricle with an interprocedural delay of 12 months were included. Disease progression was defined as 1 factor: scar area progression (PROG, +5%), ventricular remodeling (dilatation [+25 mL] or decreased ejection fraction [-5%EF]). Incomplete ablation was defined as index VT recurrence or ablation in previously unablated regions inside index scar without PROG. ResultsTwenty patients from nine centers were included (80% male 55 16years, 7 ARVC and 13 NICM, LVEF 43 +/- 14%). Mean delay was 28 +/- 18 months. Disease progression occurred in 75% with ventricular remodeling in 70%: ventricular dilation in 45% (ARVC [71%]; NICM [38%]), decreased EF in 60% [RVEF in ARVC (71%); LVEF in NICM (54%)], and scar progression in 50% (in ARVC [57%] and NICM [46%]). Index VT recurrence was observed in 40%. Redo ablation sites were located in previously unablated regions inside the index scar in 70% of patients. VT recurrence following the second procedure was seen in 25%. Fifteen percent died during a follow-up of 17 +/- 17 months. ConclusionDisease progression is the rule in ARVC and NICM while scar progression occurs in half. However, even if disease progression is frequently observed, incomplete index ablation is the most common finding, strongly suggesting the need for more extensive ablation.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of cardiovascular electrophysiology

  • ISSN

    1045-3873

  • e-ISSN

  • Volume of the periodical

    27

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    80-87

  • UT code for WoS article

    000368017000011

  • EID of the result in the Scopus database